Terjemahan ini sedang disediakan. Buat sementara, kami memaparkan versi asal dalam bahasa Inggeris.
Perniagaan · 14/11/20261 min read
CARsgen's CAR-T Product Satri-cel Included in China's Commercial Health Insurance Innovative Drug List
Terjemahan automatik tempatan · Bahasa asal sumber
Ringkasan
SHANGHAI, Nov. 14, 2026 — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that satricabtagene autoleucel…
Bahasa asal sumber: PR Newswire — Global News ReleasesBuka kenyataan asal →